SCHEMBL29720667

SCHEMBL29720667

CC(C)NC(=O)c1nc(O)c2scc(-c3ccccn3)c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 6/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
L3MBTL1 Q9Y468 6/20 0.41
MITF O75030 2/20 0.41
CCR6 P51684 1/20 0.41
KDM4A O75164 1/20 0.40
KDM4B O94953 1/20 0.40
KDM5B Q9UGL1 1/20 0.40
GABRA5 P31644 1/20 0.39
GRM1 Q13255 1/20 0.39
ADORA2A P29274 1/20 0.39
OPRK1 P41145 1/20 0.39
ALDH1A1 P00352 5/20 0.38
ALOX15 P16050 2/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 1/20 0.38
KDM4E B2RXH2 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
RAB9A P51151 1/20 0.38
CSNK2A1 P68400 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29720656 1.00 ADORA3 (0.42) ADORA3SMN1; SMN2L3MBTL1MITFCCR6
SCHEMBL24128110 1.00 ADORA3 (0.42) ADORA3SMN1; SMN2L3MBTL1MITFCCR6
SCHEMBL26038568 0.83 BRD4 (0.43) ADORA3SMN1; SMN2KDM4AKDM4BKDM5B
SCHEMBL30481834 0.83 ADORA3 (0.47) ADORA3SMN1; SMN2KDM4AKDM4BKDM5B
SCHEMBL24128111 0.83 ADORA3 (0.47) ADORA3SMN1; SMN2KDM4AKDM4BKDM5B
SCHEMBL24128116 0.83 NPC1 (0.44) ADORA3SMN1; SMN2L3MBTL1MITFKDM4A
SCHEMBL24128109 0.83 TGFBR1 (0.43) ADORA3SMN1; SMN2L3MBTL1ADORA2AALDH1A1
SCHEMBL30481876 0.83 TGFBR1 (0.43) ADORA3SMN1; SMN2L3MBTL1ADORA2AALDH1A1
SCHEMBL29720521 0.82 CSNK2A1 (0.43) ADORA3SMN1; SMN2L3MBTL1KDM4AKDM4B
SCHEMBL26042492 0.82 CSNK2A1 (0.43) ADORA3SMN1; SMN2L3MBTL1KDM4AKDM4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4168414-A1 SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE Shy Therapeutics LLC (US) 2023-04-26 EP disclosed
WO-2021257828-A9 SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2022-07-21 WO disclosed